CoreFirst Bank & Trust »

Vaneck Vectors Pharmaceutical etf shares owned by CoreFirst Bank & Trust

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by CoreFirst Bank & Trust from 13F filings

Historical chart of CoreFirst Bank & Trust investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by CoreFirst Bank & Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by CoreFirst Bank & Trust

Quarter filed Position value Share count Share price at filing
2023-12-31 $712k 8.8k 81.37
2023-09-30 $76k 950 79.86

More positions owned by CoreFirst Bank & Trust

Apple (AAPL)
Colgate-Palmolive Company (CL)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Vanguard High Dividend Yield ETF (VYM)
Ishares Tr dev val factor (IVLU)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Vanguard Dividend Appreciation ETF (VIG)
American Centy Etf Tr avantis emgmkt (AVEM)
Johnson & Johnson (JNJ)
Procter & Gamble Company (PG)
McDonald's Corporation (MCD)
Exxon Mobil Corporation (XOM)
iShares S&P 500 Index (IVV)
Vanguard Int High Dvd Yld In exchange traded funds (VYMI)

View all positions for CoreFirst Bank & Trust

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Bank of America Corporation
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
Jpmorgan Chase & Co
Miller Investment Management
Prime Capital Investment Advisors
Bnp Paribas Arbitrage, Snc
Independent Advisor Alliance
Phoenix Holdings
Citadel Advisors
Avestar Capital
Gladstone Institutional Advisory
Hrt Financial
Twelve Points Wealth Management

View all funds holding Vaneck Vectors Pharmaceutical etf